NCT03837821

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

RecruitingEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2019-02-05Est. Completion: 2024-07-02

Enrollment target: 20 participants

Locations

Weill Cornell Medicine, New York, New York, United States
UT Southwestern Medical Center - Simmons Comprehensive Cancer Center, Dallas, Texas, United States

Ganglioneuroblastoma, NodularNeuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…

Birmingham, United StatesEst. completion Dec 31, 2029

NMIBCMIBCMuscle Invasive Bladder Cancer (MIBC)Non Muscle Invasive Bladder Cancer

This study aims to better understand how treatment choices impact outcomes for patients with intermediate- and high-risk…

Dallas, United StatesEst. completion May 2032

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.